Immunogenicity of trivalent inactivated influenza vaccination received during pregnancy or postpartum

Obstetrics and Gynecology

Volumn 119, Issue 3, 2012, Pages 631-639

  Sperling, Rhoda S ^a,b   Engel, Stephanie M ^a,b   Wallenstein, Sylvan ^a,b   Kraus, Thomas A ^a,b   Garrido, Jose ^a,b   Singh, Tricia ^a,b   Kellerman, Lisa ^a,b   Moran, Thomas M ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; FEMALE; GESTATIONAL AGE; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MATERNAL WELFARE; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; SEROCONVERSION; THIRD TRIMESTER PREGNANCY;

ADULT; ANTIBODIES, VIRAL; FEMALE; GESTATIONAL AGE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; OBESITY; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VACCINES, INACTIVATED; YOUNG ADULT;

EID: 84859073171     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e318244ed20     Document Type: Article

References (30)

1. Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL, Biggerstaff MS, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009;374: 451-8.
2. The ANZIC Influenza Investigators and Australasian Maternity Outcomes Surveillance System. Critical illness due to 2009 A/H1N1 influenza in pregnant and postpartum women: population based cohort study. BMJ 2010;340:c1279.
3. Louie JK, Acosta M, Jamieson DJ, Honein MA; California Pandemic (H1N1) Working Group. Severe 2009 H1N1 Influenza in Pregnant and Postpartum Women in California. N Engl J Med 2010;362:27-35.
4. Centers for Disease Control and Prevention (CDC). 2009 pandemic influenza A(H1N1) in pregnant women requiring intensive care-New York City, 2009. MMWR Morb Mortal Wkly Rep 2010;59:321-6.
5. Siston AM, Rasmmussen SA, Honein MA, Fry AM, Seib K, Callaghan WM, et al. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA 2010;303:1517-25.
6. Mosby LG, Rasmussen SA, Jamieson DJ. 2009 pandemic influenza A(H1N1) in pregnancy: a systematic review of the literature. Am J Obstet Gynecol 2011;205:10-8.
7. Fiore AE, Shay DK, Broder K, Iskander JK, Uyeki TM, Mootrey G, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2009;58:1-52. Erratum in: MMWR Recomm Rep 2009; 58:896-7.
8. Centers for Disease Control and Prevention (CDC). Seasonal influenza and 2009 H1N1 influenza vaccination coverage among pregnant women-10 states, 2009-10 influenza season. MMWR Morb Mortal Wkly Rep 2010;59:1541-5.
9. Ding H, Santibanez TA, Jamieson DJ, Weinbaum CM, Euler GL, Grohskopf LA, et al. Influenza vaccination coverage among pregnant women-National 2009 H1N1 Flu Survey (NHFS). Am J Obstet Gynecol 2011;204:S96-106.
10. Sumaya CV, Gibbs RS. Immunization of pregnant women with influenza A/New Jersey/76 virus vaccine: reactogenicity and immunogenicity in mother and infant. J Infect Dis 1979; 140:141-6. (Pubitemid 10243083)
11. Englund, JA, Mbawuike IN, Hammill H, Holleman MC, Baxter BD, Glazen WP. Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants. J Infect Dis 1993;168:647-56. (Pubitemid 23254284)
12. Steinhoff MC, Omer SB, Roy E, Arifeen SE, Raqib R, Allaye M, et al. Influenza immunization in pregnancy-antibody responses in mothers and infants. N Engl J Med 2010;362: 1644-6.
13. Yamaguchi K, Hisano M, Isojima S, Irie S, Arata N, Watanabe N, et al. Relationship of Th1/Th2 cell balance with the immune response to influenza vaccine during pregnancy. J Med Virol 2009;81:1923-8.
14. Jackson LA, Patel SM, Swamy GK, Frey SE, Creech CB, Munoz FM, et al. Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women. J Infect Dis 2011;204:854-63.
15. Pandemic influenza A(H1N1) 2009 virus vaccine-conclusions and recommendations from the October 2009 meeting of the immunization Strategic Advisory Group of Experts. Wkly Epidemiol Rec 2009;84:505-8.
16. U.S. Food and Drug Administration, Guidance for Industry. Clinical data needed to support the licensure of seasonal inactivated influenza vaccines. Available at: http://www.fda.gov/BiologicsBloodVaccines/ GuidanceComplianceRegulatoryInformation/Guidances/Vaccines/ucm074794.htm.
17. Jackson L, Gaglani MJ, Keyserling HL, Balser J, Bouveret N, Fries L, et al. Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons. BMC Infect Dis 2010;10:71.
18. Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza, Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, Uyeki TM, et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010;362:1708-19.
19. Weber DJ, Rutala WA, Samsa GP, Santimaw JE, Lemon SM. Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine. JAMA 1985;254:3187-9. (Pubitemid 16206968)
20. Schäffler A, Schölmerich J. Innate immunity and adipose tissue biology. Trends Immunol 2010;31:228-35.
21. Zuckerman JN. The importance of injecting vaccines into muscle. Different patients need different needle sizes. BMJ 2000;321:1237-8.
22. Braden CR. Listeriosis. Pediatr Infect Dis J 2003;22:745-6. (Pubitemid 36999656)
23. Shulman CE, Dorman EK. Importance and prevention of malaria in pregnancy. Trans R Soc Trop Med Hyg 2003;97: 30-5.
24. Harger JH, Ernest JM, Thurnau GR, Moawad A, Momirova V, Landon MB, et al. Risk factors and outcome of varicella-zoster virus pneumonia in pregnant women. J Infect Dis 2002;185: 422-7. (Pubitemid 34142803)
25. Medina KL, Smithson G, Kincade PW. Suppression of Blymphopoiesis during normal pregnancy. J Exp Med 1993; 178:1507-15.
26. Grimaldi CM, Cleary J, Dagtas AS, Moussai D, Diamond B. Estrogen alters thresholds for B cell apoptosis and activation. J Clin Invest 2002;109:1625-33. (Pubitemid 34663525)
27. Mai T, Zan H, Zhang J, Hawkins JS, Xu Z, Casali P. Estrogen receptors bind to and activate the HOXC4/HoxC4 promoter to potentiate HoxC4-mediated activation-induced cytosine deaminase induction, immunoglobulin class switch DNA recombination, and somatic hypermutation. J Biol Chem 2010;285:37797-810.
28. Stavnezer J. Immunoglobulin class switching. Curr Opin Immunol 1996;8:199-205. (Pubitemid 26166985)
29. Kraus TA, Sperling RS, Engel SM, Lo Y, Kellerman L, Singh T, et al. Peripheral blood cytokine profiling during pregnancy and post-partum periods. Am J Reprod Immunol 2010;64: 411-26.
30. Pentsuk N, van der Laan JW. An interspecies comparison of placental antibody transfer: New insights into developmental toxicity testing of monoclonal antibodies. Birth Defects Res B Dev Reprod Toxicol 2009;86:328-44.